Table 1.

Characteristics of patients with relapsing-remitting multiple sclerosis (RRMS)

Patients (male/female), n	2/6
Age (years)	41 ± 7.8 (32-51)
EDSS
Baseline	4.1 ± 1.6
MS-56	4.1 ± 1.4
Disease duration (years)	6.1 ± 2.6 (3-10)
Relapses before treatment (n)	4.5 ± 1.5
Relapses during treatment (n)	0.5 ± 0.7a

Values are expressed as mean ± SE unless otherwise indicated. Baseline: patients with MS before treatment (baseline) and after 56 weeks of treatment with natalizumab (MS-56). EDSS = Expanded Disability Status Scale

^a p < 0.05 vs baseline group